# Developmental Funds

> **NIH NIH P30** · RBHS -CANCER INSTITUTE OF NEW JERSEY · 2020 · $476,270

## Abstract

DEVELOPMENTAL FUNDS
PROJECT SUMMARY/ABSTRACT
CCSG developmental funds leveraged additional institutional support and provided an exceptionally strong
return on investment. The $350,000 CCSG support of the New Investigator Award Program was
supplemented by $80,000 of institutional/philanthropic funds, allocated to eight new faculty recruits, and
generated a total of $9 million (total costs) in grant support. The $1.2 million CCSG support of the Pilot
Project Program was supplemented by $1.5 million of institutional/philanthropic funds, generating $17.8
million (total costs) in grant support. The grand total of $26.8 million return on investment (ROI) includes
over $26.6 million in peer reviewed grant support, and represents a 17.5-fold ROI of CCSG funds invested
for New Investigator Awards and Pilot Projects.
CCSG developmental funds further enabled shared resource evolution. The Metabolomics shared resource
has matured to an established shared resource that offers unique technical expertise and ease-of-access to
state-of-the-art instrumentation and current protocols that are not available in most individual investigator
laboratories; this resource continues to fuel collaborative research with Princeton University and over a recent
twelve-month period, served 19 investigators (17 of whom are CINJ members) across three CINJ programs.
Given the continued substantial growth of the CINJ research enterprise, and the successful use of
developmental funds in the current project period, we request $425,000 per year to be used in three
categories: 1) recruitment of investigators in areas of strategic priority for CINJ (New Investigator Award
program), 2) development of new shared resources in Immune Monitoring (responding to the Director’s
initiative in Immune Oncology) and Small Molecule Screening (critical to all Basic programs and specifically
responsive to a 2011 critique of the Cancer Pharmacology Program), and 3) pilot awards (Pilot Project
program) to promote novel, collaborative research aligned with strategic priorities.

## Key facts

- **NIH application ID:** 9889072
- **Project number:** 5P30CA072720-21
- **Recipient organization:** RBHS -CANCER INSTITUTE OF NEW JERSEY
- **Principal Investigator:** STEVEN K. LIBUTTI
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $476,270
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9889072

## Citation

> US National Institutes of Health, RePORTER application 9889072, Developmental Funds (5P30CA072720-21). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9889072. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*